| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/29/2010 | US20100104621 Treating adhd and other diseases involving inflammation |
| 04/29/2010 | US20100104620 Over-coated product including tableted center and medicament |
| 04/29/2010 | US20100104618 Polymer-based surgically implantable haloperidol delivery systems and methods for their production and use |
| 04/29/2010 | US20100104563 Interleukin-18 specific immunoglobulins for treatment and prevention of autoimmune, respiratory, reproductive, heart, connective tissue, liver, bone and arthritic disorders |
| 04/29/2010 | US20100104560 Botulinum neurotoxin e receptors and uses thereof |
| 04/29/2010 | US20100104537 Methods of treating Parkinson's disease using viral vectors |
| 04/29/2010 | US20100104529 TNF-alpha VACCINE FOR TREATING DISEASE CONDITIONS MEDIATED BY PATHOLOGICAL TNF-alpha |
| 04/29/2010 | US20100104512 Dendritic Chelated Compounds, Methods for Making the Same and Pharmaceutical Compositions Containing the Same |
| 04/29/2010 | US20100104510 Selenocysteine mediated hybrid antibody molecules |
| 04/29/2010 | US20100104504 Materials and methods for diagnosis, prevention and/or treatment of stress disorders and conditions associated with abeta peptide aggregation |
| 04/29/2010 | DE19823940B4 Enterische Fluoxetinpellets Enteric Fluoxetinpellets |
| 04/29/2010 | CA2741490A1 Therapeutics for neurological disorders |
| 04/29/2010 | CA2741349A1 Pyrimidine and triazine sulfonamide derivates as b1 bradykinin receptor (b1r) inhibitors for treating pain |
| 04/29/2010 | CA2741089A1 Modulation of axon degeneration |
| 04/29/2010 | CA2740810A1 Phenanthroindolizidine compound and nf.kappa.b inhibitor containing same as active ingredient |
| 04/29/2010 | CA2740807A1 Phenanthroindolizidine derivative and nf.kappa.b inhibitor containing same as active ingredient |
| 04/29/2010 | CA2739946A1 Isoquinolinone derivatives as nk3 antagonists |
| 04/29/2010 | CA2739882A1 Pharmaceutical composition improving intestinal absorption |
| 04/29/2010 | CA2739740A1 Substituted 4,5,6,7-tetrahydrothienopyridines as kcnq2/3 modulators for treating pain, epilepsy and urinary incontinence |
| 04/29/2010 | CA2735956A1 Phosphodiestarase inhibitors |
| 04/28/2010 | EP2180057A1 Vector system |
| 04/28/2010 | EP2179741A1 Methods for treatment of headaches by administraton of oxytocin |
| 04/28/2010 | EP2179735A1 Pharmaceutical composition combining lamotrigine and clonazepam, and use thereof for treating convulsive disorders and epileptic syndromes |
| 04/28/2010 | EP2179734A1 Benzoxazine and dihydroquinazoline derivatives for use in the treatment of alcohol withdrawal syndrome |
| 04/28/2010 | EP2179730A1 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 04/28/2010 | EP2179724A2 Tamper-resistant products for opioid delivery |
| 04/28/2010 | EP2178881A2 Novel 6-triazolopyridazinesulfanyl benzothiazole and benzimidazole derivatives, method for production thereof and application as medicaments and pharmaceutical compositions and novel use as met inhibitors |
| 04/28/2010 | EP2178879A2 6-cycloamino-s-(pyridazin-4-yl)imidazo[1,2-b]-pyridazine and derivatives thereof preparation and therapeutic application thereof |
| 04/28/2010 | EP2178872A1 Paliperidone derivatives |
| 04/28/2010 | EP2178850A1 Trazodone and trazodone hydrochloride in purified form |
| 04/28/2010 | EP2178844A1 Azepine derivatives as gamma-secretase inhibitors |
| 04/28/2010 | EP2178842A2 4-benzylaminoquinolines, pharmaceutical compositions containing them and their use |
| 04/28/2010 | EP2178835A1 Novel substituted piperidones as hsp inducers |
| 04/28/2010 | EP2178825A1 Method for the synthesis of a-ring aromatized acetyl minocyclines |
| 04/28/2010 | EP2178824A1 Amino acid derivatives |
| 04/28/2010 | EP2178823A1 Spiro cyclopentane compounds useful as antagonists of the h1-receptor |
| 04/28/2010 | EP2178553A1 Use of a granulin or a granulin-like compound in the therapy or prophylaxis of chronic pains |
| 04/28/2010 | EP2178525A1 Resveratrol complex and process for the preperation |
| 04/28/2010 | EP2178375A1 Pyrazoloý1,5-a¨pyrimidine derivatives |
| 04/28/2010 | EP2178373A1 Heterocycles as potassium channel modulators |
| 04/28/2010 | EP1720837B1 Derivatives of n-' (1,5-diphenyl-1h-pyrazol-3-yl) sulphonamide with cb1 receptor affinity |
| 04/28/2010 | EP1628980B1 6-arylmethyl-substituted pyrazolopyrimidines |
| 04/28/2010 | EP1590321B1 Aryl alkyl carbamate derivatives production and use thereof in therapy |
| 04/28/2010 | EP1581532B1 Pyrazolo¬3,4-b pyridine compounds, and their use as phosphodiesterase inhibitors |
| 04/28/2010 | EP1472225B1 2-piperazine-pyridines useful for treating pain |
| 04/28/2010 | EP1461339B1 Spiroazacyclic compounds as monoamine receptor modulators |
| 04/28/2010 | EP1420785B1 Substituted indeno [1,2-c]isoquinoline derivatives and methods of use thereof |
| 04/28/2010 | EP1347751B1 Methods of treating bone cancer and the pain associated therewith using endothelin antagonists |
| 04/28/2010 | EP1259606B1 Compositions useful for regulating parkin gene activity |
| 04/28/2010 | CN1923241B Medicine composition containing epimedium extract, uncaria extract, and gastrodine, and its preparation and use |
| 04/28/2010 | CN1872068B Application of medication composition of containing acetamino phenol in treating insufficiency of blood supply for brain |
| 04/28/2010 | CN1857293B Medicine composition containing wild astragaloside and paeoniforin |
| 04/28/2010 | CN1795886B Application of medication composition for preparing medicine for treating cretinism |
| 04/28/2010 | CN1742837B Compound lotus core oral liquid and its preparing method |
| 04/28/2010 | CN1703426B Humanized antibodies that recognize beta amyloid peptide |
| 04/28/2010 | CN1703199B Aggregate with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially throug |
| 04/28/2010 | CN1682719B Enteric soluble coating slow releasing tablet containing huperzine A and preparing method |
| 04/28/2010 | CN1658877B Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
| 04/28/2010 | CN1611509B Nucleic acid adaptor for specific identifying human cerebral acetylcholinesterase and its use |
| 04/28/2010 | CN1593473B Application of a pharmaceutical composition in the preparing process of medicine for treating chronic alcohol intake caused injury |
| 04/28/2010 | CN1556808B Cosmetic comprising heterocyclic compound based on N6-substituted adenine, |
| 04/28/2010 | CN1556705B 7,8,9,10-tetrahydro-6H-azepino, 6,7,8,9-tetrahydro-pyrido and 2,3-dihydro-2H-pyrrolo[2,1-b]-quinazolinone derivatives |
| 04/28/2010 | CN1496271B Method of treating diseases in association with decrease in expression of AOP-1 gene or AOP-1 and remedies for diseases |
| 04/28/2010 | CN1468307B Anti-dual integrin antibodies, compositions, methods and uses |
| 04/28/2010 | CN1416335B New self emulsifying drug delivery system |
| 04/28/2010 | CN101698649A Short-acting hypnotizing and calming compound used for anesthetization |
| 04/28/2010 | CN101698096A Plaster for treating white vein diseases and preparation method thereof |
| 04/28/2010 | CN101698095A Drug composition liniment or lotion for treating white vein diseases and preparation method thereof |
| 04/28/2010 | CN101698094A Distillate for treating white vein diseases and preparation method thereof |
| 04/28/2010 | CN101698063A Plaster for treating facial paralysis and preparation method thereof |
| 04/28/2010 | CN101698051A Application of traditional Chinese medicine composite in preparing medicine treating climacteric syndrome |
| 04/28/2010 | CN101697997A External cool refreshing liquid |
| 04/28/2010 | CN101697977A Deproteinized calf blood extractive injection and preparation method thereof |
| 04/28/2010 | CN101697968A Melatonin capsule |
| 04/28/2010 | CN101697960A Huperzine-A solid dispersion and method for preparing tablet thereof |
| 04/28/2010 | CA2642184A1 Composition containing ginseng and cinnamon |
| 04/27/2010 | USRE41289 Ultrashort acting hypnotic barbiturates |
| 04/27/2010 | USRE41287 Cyclic agonists and antagonists of C5A receptors and G Protein-coupled receptors |
| 04/27/2010 | US7705195 Screening method |
| 04/27/2010 | US7705125 Botulinum neurotoxin type E having increased biological half-life for use treatment and prevention of autonomic, neuromuscular and pain disorders |
| 04/27/2010 | US7705124 Leucine-based motif and clostridial neurotoxins |
| 04/27/2010 | US7705039 Method for treating sleep apnea |
| 04/27/2010 | US7705020 Benzimidazolone carboxylic acid derivatives |
| 04/27/2010 | US7705015 Substituted pyrroline kinase inhibitors |
| 04/27/2010 | US7704994 1-{6-[(3-Cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-3- pyridinyl}-2-pyrrolidinone and salts; histamine H3 antagonists; Alzheimer's disease; schizophrena; antiepileptic agents; analgesics; neuropathic pain; Parkinson's disease; attention deficit disorder |
| 04/27/2010 | US7704993 9-Bromo-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine; selective serotonin receptor agonists; obesity, eating disorders, psychiatric disorders, Alzheimer Disease, sexual dysfunction; erectile dysfunction; central nervous system disorders; antidiabetic agents; gastrointestinal disorders |
| 04/27/2010 | US7704991 Substituted diazabicyclo derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 04/27/2010 | US7704989 Derivatives of imidazo[1,2-a]pyridine-2-carboxamides, preparation method thereof and use of same in therapeutics |
| 04/27/2010 | US7704987 Metal complex based on 1,10-phenanthroline binds to histidine of the N-terminal loop of the peptide in such a way that the N-terminal loop (amino acid residues 1-15) is blocked or destabilised to inhibit the binding copper, zinc and iron compounds -ones of magnesium /calcium; Alzheimer,s disease |
| 04/27/2010 | US7704978 Methods for treating neuropsychiatric disorders |
| 04/27/2010 | US7704975 Modafinil compound and cyclodextrin mixtures |
| 04/27/2010 | US7704952 treating diabetes or obesity using isolated polypeptide is covalently modified with a water-soluble polymer |
| 04/27/2010 | US7704951 administering as an active ingredient selenoprotein P and/or a peptide fragment or a series of peptide fragments derived from said protein; suitably applicable to diseases with decrease in motor function |
| 04/27/2010 | US7704737 culturing with an effective amount of granulocyte-macrophage colony stimulating factor, using brain tissue cells; transplantation; treating multiple sclerosis demyelination |
| 04/27/2010 | US7704526 Sustained release composition for oral administration of drugs |
| 04/27/2010 | US7704524 Transdermal botulinum toxin administration for the treatment of spastic muscle pain |
| 04/27/2010 | CA2551038C Triazole derivatives as vasopressin antagonists |
| 04/27/2010 | CA2462939C Novel derivatives of isoquinoline, process for their preparation and pharmaceutical compositions containing them |
| 04/27/2010 | CA2431645C Methods of treating hormonal deficiencies in women undergoing estrogen replacement therapy |
| 04/27/2010 | CA2427482C Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and the alkanoyl l-carnitines with taurine chloride and glycine chloride |